Overview

AMBIO INC is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering GLATIRAMER ACETATE; ICATIBANT ACETATE (NON-STERILE); LIRAGLUTIDE, NON-STERILE, BULK DRUG SUBSTANCE; SEMAGLUTIDE; TEDUGLUTIDE NON-STERILE; TERIPARATIDE USP (ACETATE).

API / Drug Master Files

AMBIO INC holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • SEMAGLUTIDEActive2021-08-06
  • TERIPARATIDE USP (ACETATE)Active2017-06-01
  • TEDUGLUTIDE NON-STERILEActive2016-08-12
  • ICATIBANT ACETATE (NON-STERILE)Active2015-05-22
  • LIRAGLUTIDE, NON-STERILE, BULK DRUG SUBSTANCEActive2013-06-12
  • GLATIRAMER ACETATEActive2012-09-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to AMBIO INC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.